IM Cannabis Corp. (IMCC) stock
IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.49−0.00 (-0.26%)
Close on Nov 17, 2026Market cap $2.91MP/E –Yield –
IM Cannabis operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -C$11.59M. The highest annual figure on record is -C$8.25M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -C$11.59M | – |
| FY2024 | Dec 31, 2024 | -C$10.23M | – |
| FY2023 | Dec 31, 2023 | -C$12.79M | – |
| FY2022 | Dec 31, 2022 | -C$30.79M | – |
| FY2021 | Dec 31, 2021 | -C$23.04M | – |
| FY2020 | Dec 31, 2020 | -C$8.25M | – |
| FY2019 | Dec 31, 2019 | -C$10.28M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -C$2.09M | – |
| Q2 FY2025 | Jun 30, 2025 | -C$350.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -C$2.87M | – |
| Q2 FY2023 | Jun 30, 2023 | -C$1.75M | – |
| Q2 FY2022 | Jun 30, 2022 | -C$5.62M | – |
| Q2 FY2021 | Jun 30, 2021 | -C$10.72M | – |
See a number that looks wrong?